
Oxymatrine therapy for chronic hepatitis B: A randomized double-blind and placebo-controlled multi-center trial
Author(s) -
Lungen Lu,
Minghui Zeng,
Yimin Mao,
Jiqiang Li,
Mo-Bin Wan,
Chengzhong Li,
Cheng-Wei Chen,
Qingchun Fu,
Jiyao Wang,
Weimin She,
Xiong Cai,
Jun Ye,
Xingtao Zhou,
Hui Wang,
Shanming Wu,
Meifang Tang,
Jihe Zhu,
Weixiong Chen,
Hui-Quan Zhang
Publication year - 2003
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v9.i11.2480
Subject(s) - oxymatrine , medicine , placebo , hbeag , gastroenterology , adverse effect , liver function , capsule , hepatitis b virus , chronic hepatitis , surgery , hbsag , immunology , pharmacology , virus , pathology , botany , alternative medicine , biology
To evaluate the efficacy and safety of capsule oxymatrine in the treatment of chronic hepatitis B.